These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15384863)

  • 1. [Treatment of chronic hepatitis C].
    Rókusz L
    Orv Hetil; 2004 Aug; 145(32):1649-53. PubMed ID: 15384863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4.
    Soriano V; Núñez M; Sánchez-Conde M; Barreiro P; García-Samaniego J; Martín-Carbonero L; Romero M; González-Lahoz J
    Antivir Ther; 2005; 10(1):167-70. PubMed ID: 15751774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating hepatitis C infection in liver transplant recipients.
    Terrault NA; Berenguer M
    Liver Transpl; 2006 Aug; 12(8):1192-204. PubMed ID: 16868944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
    Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis C virus infection--after 12 years. Advances in the management of chronic hepatitis C].
    Pár A
    Orv Hetil; 2002 Dec; 143(48):2667-74. PubMed ID: 12501575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
    Bani-Sadr F; Lapidus N; Bedossa P; De Boever CM; Perronne C; Halfon P; Pol S; Carrat F; Cacoub P; ;
    Clin Infect Dis; 2008 Mar; 46(5):768-74. PubMed ID: 18248298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic hepatitis C in HIV-HCV coinfected patients].
    Gervais A
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B121-32. PubMed ID: 12180279
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C virus antiviral therapy in patients with cirrhosis.
    Arenas JI; Vargas HE
    Gastroenterol Clin North Am; 2004 Sep; 33(3):549-62, ix. PubMed ID: 15324943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment for chronic hepatitis C.
    Davis GL
    Rev Gastroenterol Disord; 2001; 1(2):59-72. PubMed ID: 12120176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment and prevention of hepatitis C].
    Poynard T; Ratziu V; Benhamou Y; Regimbeau C
    Rev Prat; 2000 May; 50(10):1100-7. PubMed ID: 10905096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C and liver transplantation].
    Durand F
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B82-90. PubMed ID: 12180312
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis and management of chronic hepatitis C.
    Sharara AI
    J Med Liban; 1999; 47(6):339-42. PubMed ID: 10758707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus conference. Treatment of hepatitis C.
    Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES)
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B303-20. PubMed ID: 12180305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapies for chronic hepatitis C.
    Ferguson MC
    Pharmacotherapy; 2011 Jan; 31(1):92-111. PubMed ID: 21182362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance].
    Pol S
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B264-73. PubMed ID: 12180300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.